Phosphorylated p38 <scp>MAP</scp> kinase expression by leucocytes is increased in allergic humans and associated with <scp>IgE</scp> responses
Jonathan I. Silverberg(George Washington University), Rauno Joks(State University of New York)
Cited by 1
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
|British Journal of Dermatology|2020|377
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
|Journal of Allergy and Clinical Immunology|2019|268